Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Medicinal Chemistry

• Publication date

  2010-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/092986710790192712PMID 20015045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human health risk assessment for peroxisome proliferators: more than 30 years of research.

  2009cited by this paper
• Apoptosis in cancer: Key molecular signaling pathways and therapy targets

  2009cited by this paper
• Mechanisms of clofibrate-induced apoptosis in Yoshida AH-130 hepatoma cells.

  2009cited by this paper
• PPARs Mediate Lipid Signaling in Inflammation and Cancer

  2008cited by this paper
• Time-Response Effects of Testicular Gene Expression Profiles in Sprague-Dawley Male Rats Treated with Di(n-Butyl) Phthalate

  2008cited by this paper
• Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

  2008cited by this paper
• PPARγ and Apoptosis in Cancer

  2008cited by this paper
• PPARα Ligands as Antitumorigenic and Antiangiogenic Agents

  2008cited by this paper
• ReviewArticle PPARα Ligands as Antitumorigenic and Antiangiogenic Agents

  2008cited by this paper
• Fat and beyond: the diverse biology of PPARgamma.

  2008cited by this paper
• Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis

  2008cited by this paper
• Dietary modulation of peroxisome proliferator-activated receptor gamma

  2008cited by this paper
• PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.

  2008cited by this paper
• The role for endoplasmic reticulum stress in diabetes mellitus.

  2008cited by this paper
• The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha.

  2008cited by this paper
• 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.

  2007cited by this paper
• Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

  2007cited by this paper
• FLOW CYTOMETRIC EVALUATION OF SYNERGISTIC PRO‐APOPTOTIC EFFECTS OF STATINS AND CLOFIBRATES IN IM‐9 HUMAN LYMPHOBLASTS

  2007cited by this paper
• Skeletal Muscle Susceptibility to Clofibrate Induction of Lesions in Rats

  2007cited by this paper
• Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.

  2007cited by this paper
• Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation

  2007cited by this paper
• PPARα and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK‐HEP‐1

  2007cited by this paper
• Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells.

  2006cited by this paper
• Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.

  2006cited by this paper
• Attenuation of Peroxisome Proliferator-activated Receptor γ (PPARγ) Mediates Gastrin-stimulated Colorectal Cancer Cell Proliferation*

  2006cited by this paper
• Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation.

  2006cited by this paper
• PPAR delta: a dagger in the heart of the metabolic syndrome.

  2006cited by this paper
• Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

  2006cited by this paper
• HMG-CoA reductase and PPARα are involved in clofibrate-induced apoptosis in human keratinocytes

  2006cited by this paper
• Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.

  2006cited by this paper
• Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation.

  2006cited by this paper
• A novel peroxisome proliferator–activated receptor γ ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells

  2006cited by this paper
• The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins.

  2006cited by this paper
• PPARδ: a dagger in the heart of the metabolic syndrome

  2006cited by this paper
• From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

  2006cited by this paper
• Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18.

  2006cited by this paper
• Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor γ

  2006cited by this paper
• PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.

  2006cited by this paper
• Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species.

  2005cited by this paper
• CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism.

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptor δ and γ Agonists Differentially Alter Tumor Differentiation and Progression during Mammary Carcinogenesis

  2005cited by this paper
• Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition.

  2005cited by this paper
• Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.

  2005cited by this paper
• PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.

  2005cited by this paper
• PPAR ligands: Potential therapies for metabolic syndrome

  2005cited by this paper
• Dynamic Combinatorial Networks in Nuclear Receptor-mediated Transcription*

  2005cited by this paper
• Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.

  2005cited by this paper
• Differences in cell proliferation in rodent and human hepatic derived cell lines exposed to ciprofibrate.

  2005cited by this paper
• Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.

  2005cited by this paper
• Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation.

  2004cited by this paper
• Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.

  2004cited by this paper
• Activation of nuclear hormone receptor peroxisome proliferator–activated receptor-δ accelerates intestinal adenoma growth

  2004cited by this paper
• Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA

  2004cited by this paper
• Death receptor-induced cell killing.

  2004cited by this paper
• PPAR gamma signaling exacerbates mammary gland tumor development.

  2004cited by this paper
• Calcineurin and Calcium/Calmodulin-dependent Protein Kinase Activate Distinct Metabolic Gene Regulatory Programs in Cardiac Muscle*

  2004cited by this paper
• The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis.

  2004cited by this paper
• Peroxisome-proliferator-activated receptors and cancers: complex stories

  2004cited by this paper
• Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.

  2004cited by this paper
• Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ

  2004cited by this paper
• Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance

  2004cited by this paper
• An overview of the effect of linoleic and conjugated‐linoleic acids on the growth of several human tumor cell lines

  2004cited by this paper
• PPARδ is a very low-density lipoprotein sensor in macrophages

  2003cited by this paper
• Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.

  2003cited by this paper
• PPARdelta is a very low-density lipoprotein sensor in macrophages.

  2003cited by this paper
• From the Cover: PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages

  2003cited by this paper
• Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

  2003cited by this paper
• Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator.

  2003cited by this paper
• Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease

  2003cited by this paper
• Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ

  2003cited by this paper
• Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome

  2003influential reference
• Mechanisms involved in growth inhibition induced by clofibrate in hepatoma cells.

  2003cited by this paper
• Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase.

  2003influential reference
• Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

  2002cited by this paper
• WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.

  2002cited by this paper
• Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

  2002cited by this paper
• The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling

  2002cited by this paper
• Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

  2002cited by this paper
• An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis*

  2002cited by this paper
• WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo1

  2002cited by this paper
• Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.

  2002cited by this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.

  2002cited by this paper
• The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

  2002cited by this paper
• Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.

  2001cited by this paper
• Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells.

  2001cited by this paper
• Early de Novo Gene Expression Is Required for 15-Deoxy-Δ12,14-prostaglandin J2-induced Apoptosis in Breast Cancer Cells*

  2001cited by this paper
• Characterization of Clofibrate-induced Retrograde Golgi Membrane Movement to the Endoplasmic Reticulum: Clofibrate Distinguishes the Golgi from the Trans Golgi Network

  2001cited by this paper
• PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.

  2001cited by this paper
• Peroxisome Proliferator-activated Receptor γ-mediated Transcriptional Up-regulation of the Hepatocyte Growth Factor Gene Promoter via a Novel Composite cis-Acting Element*

  2001cited by this paper
• Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from genes to physiology.

  2001cited by this paper
• Peroxisome proliferator-activated receptors in inflammation control.

  2001cited by this paper
• Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer

  2001cited by this paper
• Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

  2000cited by this paper
• Cross-Talk between Two Cysteine Protease Families

  2000cited by this paper
• Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.

  2000cited by this paper

• Identification of gene signatures associated with lactation for predicting prognosis and treatment response in breast cancer patients through machine learning

  2025cites this paper
• Peroxisome Proliferator Activator α Agonist Clofibrate Induces Pexophagy in Coconut Oil-Based High-Fat Diet-Fed Rats

  2024cites this paper
• Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines.

  2019cites this paper
• The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions.

  2018cites this paper
• Clofibrate as an Adjunct to Phototherapy for Unconjugated Hyperbilirubinemia in Term Neonates

  2017cites this paper
• Improved Mitochondrial and Methylglyoxal‐Related Metabolisms Support Hyperproliferation Induced by 50 Hz Magnetic Field in Neuroblastoma Cells

  2016cites this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cites this paper
• What is important about the effect of clofibrate on neonatal hyperbilirubinemia?

  2013cites this paper
• Clofibrate for unconjugated hyperbilirubinemia in neonates: A systematic review

  2012cites this paper
• AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells

  2012cites this paper
• Structure-activity relationship analyses of glycyrrhetinic acid derivatives as anticancer agents.

  2011cites this paper